President Trump promised the nation that he would do everything in his power to provide a COVID-19 vaccine and despite how the election has turned out and he may not be the one sitting in the White House in a couple of weeks, he still stands by his word because he really cares about the health and safety of American citizens.
The federal government’s Operation Warp Speed has been working quickly to make a plan for private pharmaceutical companies to get their products tested and distributed to the public. Pfizer and BioNtech have had successful test results in their vaccine trials and they are on the fast track for approval.
From NPR:
Pfizer is ready to ask the Food and Drug Administration to authorize emergency use of the company’s COVID-19 vaccine, after an updated analysis of the clinical trial data found the vaccine to be 95% effective.
The results from the final efficacy analysis of the vaccine study were released Wednesday. An interim analysis released Nov. 9 had indicated the vaccine was more than 90% effective.
In the Phase 3 study involving more than 43,000 volunteers, half received the experimental vaccine and half got a placebo. Participants received two shots, spaced 21 days apart.
In a news release describing the trial, Pfizer and its partner BioNTech reported there were 170 cases of COVID-19 among the participants: 162 cases in the people who got the placebo compared with eight seen in volunteers who got the vaccine. Ten cases of severe COVID-19 were seen in the trial: nine of them occurred in the placebo group and one was in the vaccinated group.
First in line to receive the vaccine would be front-line health workers, first responders, and the high-risk community then it would become readily available to the general public. The entire process could take as little as a few months.
